A lovely leap toward the development of breast cancer therapy with long non-coding RNAs

Breast cancer is among the most popular malignancies by affecting over 10% of women in Western countries (1). It is a highly heterogeneous cancer with various clinical and pathological phenotypes. Due to its popularity and significant threat to the patients’ life, numerous efforts have been conducted for this malignancy in order to establish classification and staging, make early and accurate diagnosis and to develop effective therapeutic regimens (1).